Ogo Egbuna
About Ogo Egbuna
Vice President of Clinical Development
Ogo Egbuna serves as the Vice President of Clinical Development. In this role, he leads clinical development programs focused on genetic kidney diseases. His work is critical in advancing treatment strategies and improving patient outcomes for those suffering from these conditions.
Harvard Medical School Experience
Before his current position, Ogo Egbuna was a kidney and pancreas transplant physician at Harvard Medical School. This experience provided him with extensive knowledge and hands-on expertise in the treatment and management of complex kidney conditions, equipping him for his current leadership role.
Focus on Kidney Health Awareness
Ogo Egbuna is deeply passionate about kidneys and their role in filtering blood and maintaining body balance. He is dedicated to raising awareness about kidney health and the significance of genetic kidney diseases. His work aims to educate the public and healthcare professionals on the importance of early diagnosis and proactive treatment.
Advancements in APOL1-mediated Kidney Disease
Ogo Egbuna is involved in advancing the understanding and treatment of APOL1-mediated kidney disease (AMKD). His efforts focus on developing innovative clinical approaches to address the genetic factors influencing this condition, thus improving therapeutic options for affected patients.